Lung cancer in Pakistan, where do we stand?

被引:0
|
作者
Majeed, Farhan Ahmed [1 ]
Azeem, Abdul Rehman [2 ]
Farhan, Nabeela [3 ]
机构
[1] CMH Lahore, Dept Surg, Lahore, Pakistan
[2] CMH Lahore, Lahore, Pakistan
[3] Cantonment Board Hosp, Rawalpindi, Pakistan
关键词
Lung cancer; GLOBOCON; PHRC; Cancer registry; Mortality;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lung cancer is the most common cancer in males and second most common in females after breast cancer. We have compared our data with the international statistics to see where do we stand. In Pakistan, we do not have a valid central cancer registry at present which can provide a true picture of lung cancer. Therefore, we used statistics of GLOBOCON 2012, in order to evaluate the true burden of lung cancer in our population through the recently established data by PHRC (Pakistan Health and Research council). Our analysis showed that data depicting true incidence and mortality of lung cancer in Pakistan are lacking. GLOBOCON 2012 placed lung cancer as the 3rd most common cancer in Pakistan while PHRC 2016 placed it as the 10th most common cancer irrespective of the rise in smoking incidence in Pakistan over the past one decade. This calls for an urgent need to formulate a valid central cancer registry in the country in association with the local bodies.
引用
收藏
页码:405 / 408
页数:4
相关论文
共 50 条
  • [1] Lung cancer screening: where do we stand?
    Hardavella, Georgia
    Frille, Armin
    Sreter, Katherina Bernadette
    Atrafi, Florence
    Yousaf-Khan, Uraujh
    Beyaz, Ferhat
    Kyriakou, Fotis
    Bellou, Elena
    Mullin, Monica L.
    Janes, Sam M.
    [J]. BREATHE, 2024, 20 (02)
  • [2] Squamous Cell Lung Cancer: Where Do We Stand and Where Are We Going?
    Hirsch, Fred R.
    [J]. ONCOLOGY-NEW YORK, 2013, 27 (09): : 914 - 915
  • [3] Particle therapy in lung cancer: Where do we stand?
    Pijls-Johannesmata, Madelon
    Grutters, Janneke P. C.
    Lambin, Philippe
    De Ruysscher, Dirk
    [J]. CANCER TREATMENT REVIEWS, 2008, 34 (03) : 259 - 267
  • [4] Gut Microbiota in Lung Cancer: Where Do We Stand?
    Georgiou, Konstantinos
    Marinov, Blagoi
    Farooqi, Ammad Ahmad
    Gazouli, Maria
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (19)
  • [5] Lung cancer in Eastern Morocco: where do we stand?
    Belmokhtar, Karam Yahya
    Tajir, Mariam
    Boulouiz, Redouane
    Bennani, Amal
    Brahmi, Sami Aziz
    Alloubi, Ihsan
    Kouismi, Hatim
    Kamaoui, Imane
    Skiker, Imane
    Afqir, Said
    Abda, Naima
    Bellaoui, Mohammed
    Mezouar, Loubna
    [J]. PAN AFRICAN MEDICAL JOURNAL, 2019, 34
  • [6] Hepatocellular Carcinoma in Pakistan: Where do We Stand?
    Butt, Amna Subhan
    Abbas, Zaigham
    Jafri, Wasim
    [J]. HEPATITIS MONTHLY, 2012, 12 (10)
  • [7] Postoperative radiation therapy for lung cancer: Where do we stand?
    Kelsey, Chris R.
    Marks, Lawrence B.
    Wilson, Lynn D.
    [J]. ONCOLOGY-NEW YORK, 2008, 22 (03): : 301 - 310
  • [8] Noninvasive biomarkers for lung cancer diagnosis, where do we stand?
    Kammer, Michael N.
    Massion, Pierre P.
    [J]. JOURNAL OF THORACIC DISEASE, 2020, 12 (06) : 3317 - 3330
  • [9] Commentary: Early diagnosis of lung cancer: Where do we stand?
    Paleari, Laura
    Granone, Pierluigi
    Grozio, Alessia
    Cesario, Alfredo
    Russo, Patrizia
    [J]. ONCOLOGIST, 2007, 12 (12): : 1433 - 1436
  • [10] Hepatitis E Vaccination in Pakistan: Where Do We Stand
    Khan, Jibran Umar Ayub
    Qaiser, Ayesha
    Shah, Azhar Zahir
    [J]. ANNALS OF KING EDWARD MEDICAL UNIVERSITY LAHORE PAKISTAN, 2022, 28 (04): : 2 - 2